- Trial of Short Course Chemotherapy for Pulmonary Tuberculosis
-
- KMID: 2528912
- Tuberc Respir Dis.
- 1978 Dec;25(4):161-164.
- doi: 10.4046/trd.1978.25.4.161
A clinical trial of nine months conbined chemotherapy including rifampicin for initial case of pulmonary tuberculosis proven by sputum AFB smear positive in 50 patients was done and its results... -
- CITED
-
- Close
- SHARE
-
- Close
- Rifampicin-induced Tubulo-interstitial Nephritis - A case report -
-
- KMID: 2528914
- Tuberc Respir Dis.
- 1978 Dec;25(4):170-174.
- doi: 10.4046/trd.1978.25.4.170
One case of acute renaI failure foIIowing rifampicin administration is presented with brief review. Acute renaI failure developed in a 49-year-old male who had had far advanced pulmonary tuberculosis and taken... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Studies on Relationship with Sinusitis and Bronchiectasis
-
- KMID: 2528913
- Tuberc Respir Dis.
- 1978 Dec;25(4):165-169.
- doi: 10.4046/trd.1978.25.4.165
Forty one cases of confirmed bronchiectasis were studied as to the coexistence of sinusits. Sinusitis was detected in 28 out of 41 patients with bronchiectasis (68.3%) and it was coexisted more... -
- CITED
-
- Close
- SHARE
-
- Close
- A Socio-medical Study on Newly Registered Patients of Pulmonary Tuberculosis at Urban Health Centers
-
- KMID: 2528910
- Tuberc Respir Dis.
- 1978 Dec;25(4):139-148.
- doi: 10.4046/trd.1978.25.4.139
A socio-medical study was conducted with 748 tuberculosis(TB) patients newly registered at 9 health centers in Seoul City for 2 months, July and August 1976. They were questioned on 3... -
- CITED
-
- Close
- SHARE
-
- Close
- The Clinical Trends and Results of Patient Treated on TB Clinic of Koje Island Community Health Project
-
- KMID: 2528911
- Tuberc Respir Dis.
- 1978 Dec;25(4):149-160.
- doi: 10.4046/trd.1978.25.4.149
The folIowing are the results of a thorough investigation of the newly registered pulmonary TB patients at the TB clinic of Koje Island Community Health Project for the 4 years... -
- CITED
-
- Close
- SHARE
-
- Close
